Intravenous form of omeprazole will be replaced by oral form in patients with ulcer bleeding
The results of the research suggest the same therapeutic efficacy of oral and intravenous forms of omeprazole in patients with peptic ulcer bleeding. This formulation should be administered at a high dose (orally first dose of 80 mg and then 40 mg every 12 hours). Use of oral omeprazole is more cost-effective due to the cheaper cost of pills and the ability to discharge patients from a hospital in the earlier terms Proton pump inhibitors are more effective and more cost-effective compared to H2-blokers in patients with ulcer blee-ding. Most researchers believe that in the nearest future will be need to revise existing guidelines for the management of patients with ulcer bleeding in favor of replacing the recommendations on the use of intravenous forms of proton pump inhibitors on oral.
Full Text:PDF (Русский)
Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding / Barkun A.N., Cockeram A.W., Plourde V., Fedorak R.N. // Aliment. Pharmacol. Ther. — 1999. — V. 13, № 12. — P. 1565-1584.
Pang S.H., Graham D.Y. A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers // Therap. Adv. Gastroenterol. — 2010. — V. 3, № 1. — P. 11-22.
Trang T., Chan J., Graham D.Y. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21st century // World Journal of Gastroenterology. — 2014. — Article in press.
Leontiadis G.I., Sharma V.K., Howden C.W. Proton pump inhibitor treatment for acute peptic ulcer bleeding // Cochrane Database Syst. Rev. — 2006. — V. 25, № 1. — CD002094.
Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer / Javid G., Zargar S.A., U-Saif R. et al. // J. Gastroenterol. Hepatol. — 2009. — V. 24, № 7. — P. 1236-1243.
Laine L., Shah A., Bemanian S. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers // Gastroenterology. — 2008. — V. 134, № 7. — P. 1836-1841.
Tsoi K.K., Hirai H.W., Sung J.J. Meta-analysis: comparison of oral vs. intravenous proton pump inhibitors in patients with peptic ulcer bleeding // Aliment. Pharmacol. Ther. — 2013. — V. 38, № 7. — P. 721-728.
Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding / Neumann I., Letelier L.M., Rada G. et al. // Cochrane Database Syst. Rev. — 2013. — V. 6. — CD007999.
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials / Wang C.H., Ma M.H., Chou H.C. et al. // Arch. Intern. Med. — 2010. — V. 170, № 9. — P. 751-758.
The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding / Barkun A.N., Herba K., Adam V. et al. // Aliment. Pharmacol. Ther. — 2004. — V. 20, № 2. — P. 195-202.
The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage / Spiegel B.M., Dulai G.S. Lim B.S. et al. // Clin. Gastroenterol. Hepatol. — 2006. — V. 4, № 8. — P. 988-997.
Red Book of Average Wholesale Drug Prices. — Montvale, N.J. Thompson Medical Economics, 2005.
- There are currently no refbacks.
Copyright (c) 2016 GASTROENTEROLOGY
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2017